Search

everythinglearnresearchcommunity

for

Search:↓

Overexpressing SSAT in mice makes them highly sensitive to polyamine analogues, causing liver damage and high mortality.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

3α-androstanediol helps reduce age-related cognitive and mood declines in male rats, unlike testosterone.

Daily low-dose aspirin lowers minoxidil's effectiveness for hair loss treatment.

The combination of arginine and zinc reduces hair loss and increases hair growth effectively.

Finasteride treatment makes the prostate look more like a healthy one.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

DHEA supplementation may improve quality of life, neuropsychological functions, and sexual satisfaction in individuals with adrenal insufficiency, but more research is needed to confirm its safety and effectiveness.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The dietary supplement AGA-P improves the effectiveness of hair loss treatments.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

The method effectively measures drug impact on DHT levels in prostate treatments.

Adjusting polyamine levels could help treat skin disorders like psoriasis and skin cancer.

DK peptides can reduce hair loss by inhibiting the 5α-reductase enzyme and have antioxidant effects.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

A rare gene variant causes sexual development issues in siblings, needing personalized treatment.

New SRD5A2 variants may disrupt protein function, aiding diagnosis and treatment of related disorders.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

A dissolving microneedle patch with dutasteride offers effective, long-lasting hair loss treatment with fewer side effects.

Young men taking finasteride for hair loss have a higher risk of sexual dysfunction.

Finasteride safely lowers DHT levels without affecting testosterone.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Men with androgenetic alopecia may have higher triglycerides, suggesting a link to lipid metabolism.